Latest Asset Impairment News

Close the Loop Limited has sold its ISP Tek Services business for US$10 million, slashed US$16 million of debt, and set an optimistic EBITDA target of $14 million to $16 million for FY27, signalling a sharper focus on its packaging and resource recovery strengths.

Marimaca Copper Corp. reported a robust cash position of $147.7 million in Q1 2026, driven by a C$409 million equity raise, supporting ongoing development of its Marimaca Project in Chile.

CSL Limited’s interim CEO Gordon Naylor reveals a downgraded FY26 outlook amid slower growth and announces substantial impairments tied to CSL Vifor assets. Leadership changes and transformation efforts aim to restore momentum.

Universal Store Holdings has posted a 14% rise in retail sales for the first 43 weeks of FY26, buoyed by strong like-for-like growth across its brands. However, ongoing wholesale challenges at CTC have triggered a $24 million impairment, even as the group maintains its full-year sales and EBITA guidance.

Treasury Wine Estates is reshaping its global operations into four regional divisions to sharpen market execution and efficiency. The company reports improved third-quarter sales in China and the US, bolstered by luxury brand Penfolds, while securing $300 million in new debt to strengthen liquidity beyond $1 billion by fiscal 2026 end.

DGL Group Limited has agreed to sell two chlor-alkali manufacturing plants for $2.5 million, well below their carrying value, reflecting a $5.3 million impairment charge. The sale aligns with the company’s strategic focus on core operations and is not expected to materially affect ongoing activities.

Novo Resources Corp. reported a net loss of CAD 22.4 million for 2025, slightly improving from the previous year, while securing a $5.9 million capital raise to support ongoing exploration and operations.

Image Resources NL is set to record significant non-cash impairments totalling around A$61 million in its 2025 financial results, reflecting challenges from weaker mineral sands prices and a stronger Australian dollar.

Peak Processing Limited reported a sharp 47.7% revenue drop and a 257.7% increase in losses for H1 2026, alongside a significant asset impairment and ongoing going concern concerns.

Argent BioPharma reported a significantly reduced half-year loss of A$2.9 million, progressing a strategic acquisition to bolster its CannEpil drug pipeline and securing up to A$11 million in new funding.

HALO Technologies reports a strategic pivot towards APAC growth and a UK business model overhaul, alongside a 16% revenue decline and increased net loss in FY25.

Halo Technologies Holdings Ltd posted a $17.4 million loss for 2025, widening from $14.5 million the previous year, as revenue fell 16%. The company completed a $3.9 million rights issue and announced a strategic pivot in its UK operations.